Neuroendocrine differentiation in human prostatic tumor models

American Journal of Pathology

Volumn 149, Issue 3, 1996, Pages 859-871

  Noordzij, Marinus A ^a   Van Weerden, Wytske M ^a   De Ridder, Corrina M A ^a   Van Der Kwast, Theodorus H ^a   Schröder, Fritz H ^a   Van Steenbrugge, Gert Jan ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CYTOPLASMIC GRANULES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; NEUROSECRETORY SYSTEMS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029781016     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Pearse AGE: The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic, and pathologic implications of the concept. J Histochem Cytochem 1969, 17:303-313
2. Erlandson RA, Nesland JM: Tumors of the endocrine/ neuroendocrine system: an overview. Ultrastruct Pathol 1994, 18:149-170
3. Noordzij MA, van Steenbrugge GJ, van der Kwast TH, Schröder FH: Neuroendocrine cells in the normal, hyperplastic, and neoplastic prostate. Urol Res 1995, 22:333-341
4. Grube D: The endocrine cells of the digestive system amines, peptides, and modes of action. Anat Embryol 1986, 175:151-162
5. Sjoberg HE, Arver S, Bucht E: High concentration of immunoreactive calcitonin of prostatic origin in human semen. Acta Physiol Scand 1980, 110:101-102
6. Gershagen S, Cockett ATK, Lilja H, Iwamura M: Parathyroid hormone-related protein is a substrate for prostate specific antigen. J Urol 1995, 153(suppl):267
7. Noordzij MA, van der Kwast TH, van Steenbrugge GJ, Hop WJC, Schröder FH: The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomy. Int J Cancer 1995, 62:252-258
8. Di Sant'Agnese PA: Neuroendocrine differentiation in carcinoma of the prostate: diagnostic, prognostic, and therapeutic implications. Cancer 1992, 70:254-268
9. Di Sant'Agnese PA, De Mesy Jensen KL: Endocrine-paracrine cells of the prostate and prostatic urethra: an ultrastructural study. Hum Pathol 1984, 15:1034-1041
10. Abrahamsson PA, Wadström LB, Alumets J, Falkmer S, Grimelius L: Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Pathol Res Pract 1986, 181:675-683
11. Ghadially FN: Ultrastructural pathology of the cell and matrix. London, Butterworths, 1988, pp 364-389
12. Winkler H, Fischer Colbrie R: The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 1992, 49:497-528
13. Rosa P, Gerdes HH: The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors. J Endocrinol Invest 1994, 17: 207-225
14. Seuwen K, Pouyssegur J: Serotonin as a growth factor. Biochem Pharmacol 1990, 39:985-990
15. Dalsgaard CJ, Hultgardh Nilsson A, Haegerstrand A, Nilsson J: Neuropeptides as growth factors: possible roles in human diseases. Regul Pept 1989, 25:1-9
16. Bologna M, Festuccia C, Muzi P, Biordi L, Ciomei M: Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 1989, 63:1714-1720
17. Krijnen JLM, Janssen PJA, Ruizeveld de Winter JA, van Krimpen H, Schröder FH, van der Kwast TH: Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochem 1993, 100:393-398
18. Bonkhoff H, Stein U, Remberger K: Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol 1995, 26: 167-170
19. Kaighn ME, Lechner JF, Narayan KS, Jones LW: Prostate carcinoma: tissue culture cell lines. Natl Cancer Inst Monogr 1978, 49:17-21
20. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978, 21:274-281
21. Iizumi T, Yazaki T, Kanoh S, Kondo I, Koiso K: Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J Urol 1987, 137:1304-1306
22. Horoszewicz JS, Leong SS, Kawinski E, Karr J, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 1983, 43:1809-1818
23. Hoehn W, Wagner M, Riemann JF, Hermanek P, Williams E, Walther R, Schrueffer R: Prostatic adenocarcinoma PC-EW: a new human tumor line transplantable in nude mice. Prostate 1985, 5:445-452
24. Hoehn W, Schröder FH, Riemann JF, Joebsis AC, Hermanek P: Human prostatic adenocarcinoma: some characteristics of a serially transplantable line in nude mice (PC 82). Prostate 1980, 1:95-104
25. van Steenbrugge GJ, van Weerden WM, de Ridder CMA, van der Kwast TH, Schröder FH: Development and application of prostatic xenograft models for the study of human prostate cancer. Sex Hormones and Antihormones in Endocrine Dependent Pathology: Basic and Clinical Aspects. Edited by M Motta, M Serio. Amsterdam, Elsevier Science, 1995, pp 11-20
26. van Steenbrugge GJ, van Uffelen CJ, Bolt J, Schröder FH: The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity. J Steroid Biochem Mol Biol 1991, 40:207-214
27. van Steenbrugge GJ, Groen M, de Jong FH, Schröder FH: The use of steroid-containing silastic implants in male nude mice: plasma hormone levels and the effect of implantation on the weights of the ventral prostate and seminal vesicles. Prostate 1984, 5:639-647
28. Schutte B, Reynders MM, Bosman FT, Blijham GH: Studies with anti-bromodeoxyuridine antibodies. II. Simultaneous immunocytochemical detection of antigen expression and DNA synthesis by in vivo labeling of mouse intestinal mucosa. J Histochem Cytochem 1987, 35:371-374
29. Maddox PH, Jenkins D: 3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion J Clin Pathol 1987, 40:1256-1257
30. Wilson BS, Lloyd RV: Detection of chromogranin A in neuroendocrine cells with a monoclonal antibody. Am J Pathol 1984, 115:458-468
31. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991, 39:741-748
32. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, van der Kwast TH. Androgen receptor expression in human tissues: an immunohistochemical study. J Histochem Cytochem 1991, 39:927-936
33. Key G, Becker MHG, Baron B, Duchrow M, Schlueter C, Flad H, Gerdes J: New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993, 68:629-636
34. Noordzij MA, van der Kwast TH, van Steenbrugge GJ, van Weerden W, Oomen MHA, Schröder FH: Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues. Prostate 1995, 27:154-159
35. Ponder BA, Wilkinson MM: Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry. J Histochem Cytochem 1981, 29:981-984
36. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:245-248
37. van Weerden WM, van Kreuningen A, Elissen NMJ, Vermeij M, de Jong FH, van Steenbrugge GJ, Schröder FH: Castration induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice. Prostate 1993, 23:149-164
38. Abrahamsson PA, Falkmer S, Fait K, Grimelius L: The course of neuroendocrine differentiation in prostatic carcinomas: an immunohistochemical study testing chromogranin A as an "endocrine marker". Pathol Res Pract 1989, 185:373-380
39. Dauge MC, Delmas V: APUD type endocrine tumour of the prostate: incidence and prognosis in association with adenocarcinoma. Prog Clin Biol Res 1987, A:529-531
40. Cohen RJ, Glezerson G, Haffejee Z: Neuroendocrine cells: a new prognostic parameter in prostate cancer. Br J Urol 1991, 68:258-262
41. Aprikian A, Cordon Cardo C, Fair WR, Zhang Z, Bazinett M, Hamdy SM, Reuter VE: Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol 1994, 151:914-919
42. Cohen MK, Arber DA, Coffield S, Keegan GT, McClintock J, Speights VO: Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression. Cancer 1994, 1903, 74:1899
43. 2+ transients. Endocrinology 1994, 134:596-602
44. van Haaften Day C, Raghavan D, Russell P, Wills EJ, Gregory P, Tilley W, Horsfall DJ: Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma. Prostate 1987, 11:271-279
45. Hoosein NM, Logothetis CJ, Bandyk MG, Nicolson GL, Chung LWK: Expression of neuroendocrine factors and extracellular matrix degradative enzymes in human prostate tumor cells. J Urol 1993, 149(suppl):479
46. de Bruïne AP, Dinjens WNM, van der Linden EPM, Pijls MMJ, Moerkerk PT, Bosman FT: Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells. Am J Pathol 1993, 142:773-782
47. Deftos LJ, Gazdar AF, Hogue-Angeletti R, Mullen PS, Burton DW: Distinct patterns of chromogranin A-related species can be demonstrated in endocrine cells. Bone Miner 1990, 9:169-178
48. Kalina M, Grimelius L: Chromogranins or chromogranin-like proteins are present in lamellar bodies and pulmonary surfactant of rat alveolar type II cells, J Histochem Cytochem 1991, 39:213-220
49. Letic-Gavrilovic A, Abe K: Localization of chromogranins, non-neuron-specific enolase, and different forms of somatostatins in the submandibular salivary glands of mice. J Dent Res 1990, 69:1494-1499
50. Bang YJ, Pirnia F, Fang WG, Kang WK, Sartor O, Whitesell L, Ha MJ, Tsokos M, Sheahan MD, Nguyen P, Niklinski WT, Myers CE, Trepel JB: Terminal neuroen-docrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci USA 1994, 91:5330-5334
51. Bonkhoff H, Wernert N, Dhom G, Remberger K: Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate 1991, 19:91-98
52. Civantos F, Marcial MA, Banks ER, Ho CK, Speights VP, Drew PA, Murphy WM, Soloway MS: Pathology of androgen deprivation therapy in prostate carcinoma. Cancer 1995, 75:1634-1641
53. Anouar Y, Duval J Direct estradiol down-regulation of secretogranin II and chromogranin A mRNA levels in rat pituitary cells. Mol Cell Endocrinol 1992, 88: 97-104
54. Anouar Y, Benie T, De Monti M, Counis R, Duval J: Estradiol negatively regulates secretogranin II and chromogranin A messenger ribonucleic acid levels in the female rat pituitary but not in the adrenal. Endocrinology 1991, 129:2393-2399